OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients with ATTR Amyloidosis

Trial Identifier: D8450R00004
Sponsor: AstraZeneca
NCTID:: NCT06355934
Start Date: August 2023
Primary Completion Date: September 2026
Study Completion Date: September 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Denmark Horsens, Denmark
Japan Tokyo, Japan
Spain A Coruna, Spain
Spain Barcelona, Spain
Spain Bilbao, Spain
Spain El Palmar, Spain
Spain Huelva, Spain
Spain Las Palmas de Gran Canaria, Spain
Spain Madrid, Spain
Spain Majadahonda, Spain
Spain Palma de Mallorca, Spain
Spain Salamanca, Spain
Spain Valencia, Spain
Sweden Sodertalje, Sweden
Sweden Umea, Sweden
UK London, UK
USA, Minnesota Eden Prairie, Minnesota, USA, 55344